Feds Defend 10-Year Sentence For InterMune Exec

Law360, New York (December 16, 2010, 2:10 PM EST) -- Federal prosecutors are standing by their argument that an executive of drugmaker InterMune Inc. should go to prison for 10 years for fraudulently marketing one of the company's products for a deadly lung disease it was not approved to treat.

According to a new sentencing memorandum filed Wednesday in the U.S. District Court for the Northern District of California, prosecutors' initial $20 million loss calculation is accurate, yielding a 10-year prison term for Dr. W. Scott Harkonen, but they offered Judge Marilyn Patel four alternate ways...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.